Abstract:Cholangiopathies, which affect extrahepatic bile ducts (EHBDs), include biliary atresia, primary sclerosing cholangitis, and cholangiocarcinoma. They have no effective therapeutic options. Tools to study EHBD are very limited. Our purpose was to develop an organ-specific, versatile, adult stem cell-derived, preclinical cholangiocyte model that can be easily generated from wild type and genetically engineered mice. Thus, we report on the novel technique of developing an EHBD organoid (EHBDO) culture system from adult mouse EHBDs. The model is cost-efficient, able to be readily analyzed, and has multiple downstream applications. Specifically, we describe the methodology of mouse EHBD isolation and single cell dissociation, organoid culture initiation, propagation, and long-term maintenance and storage. This manuscript also describes EHBDO processing for immunohistochemistry, fluorescent microscopy, and mRNA abundance quantitation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). This protocol has significant advantages in addition to producing EHBD-specific organoids. The use of a conditioned medium from L-WRN cells significantly reduces the cost of this model. The use of mouse EHBDs provides almost unlimited tissue for culture generation, unlike human tissue. Generated mouse EHBDOs contain a pure population of epithelial cells with markers of endodermal progenitor and differentiated biliary cells. Cultured organoids maintain homogenous morphology through multiple passages and can be recovered after a long-term storage period in liquid nitrogen. The model allows for the study of biliary progenitor cell proliferation, can be manipulated pharmacologically, and may be generated from genetically engineered mice. Future studies are needed to optimize culture conditions in order to increase plating efficiency, evaluate functional cell maturity, and direct cell differentiation. Development of co-culture models and a more biologically neutral extracellular matrix are also desirable.

Bioengineered Tubular Biliary Organoids

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

A Novel 3d Liver Organoid System for Elucidation of Hepatic Glucose Metabolism

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma

Mass Generation and Long-term Expansion of Hepatobiliary Organoids from Adult Primary Human Hepatocytes

In vitro construction of liver organoids with biomimetic lobule structure by a multicellular 3D bioprinting strategy

In Situ Differentiation and Generation of Functional Liver Organoids from Human Ipscs in a 3D Perfusable Chip System.

Human liver organoids: From generation to applications

Bioengineering of a CLiP‐derived tubular biliary‐duct‐like structure for bile transport in vitro

Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulation

Liver and bile duct organoids and tumoroids

Liver ductal organoids reconstruct intrahepatic biliary trees in decellularized liver grafts

Organization of Liver Organoids Using Raschig Ring-Like Micro-Scaffolds and Triple Co-Culture: Toward Modular Assembly-Based Scalable Liver Tissue Engineering.